127 related articles for article (PubMed ID: 1509756)
1. Improving the specificity of digoxin immunoassays.
Valdes R
Wien Klin Wochenschr Suppl; 1992; 191():55-9. PubMed ID: 1509756
[TBL] [Abstract][Full Text] [Related]
2. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay.
Schlebusch H; Jarausch J; Domke I
Wien Klin Wochenschr Suppl; 1992; 191():59-66. PubMed ID: 1509757
[TBL] [Abstract][Full Text] [Related]
3. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
Matheke ML; Valdes R
Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
[TBL] [Abstract][Full Text] [Related]
4. Practical aspects of monitoring cardiac drugs in the blood.
Wieland H
Wien Klin Wochenschr Suppl; 1992; 191():48-51. PubMed ID: 1509754
[TBL] [Abstract][Full Text] [Related]
5. [The significance of digoxin-like immunoreactive factor (DLIF) for intensive care medicine].
Simon HB; Behrendt W; Stein T
Anasth Intensivther Notfallmed; 1990 Jun; 25(3):235-6. PubMed ID: 2168132
[TBL] [Abstract][Full Text] [Related]
6. Discordant results from "real-world" patient samples assayed for digoxin.
Jones TE; Morris RG
Ann Pharmacother; 2008 Dec; 42(12):1797-803. PubMed ID: 19033482
[TBL] [Abstract][Full Text] [Related]
7. [Digoxin-like immunoreactivity in newborn infants--a pitfall of digoxin therapy?].
Heise HR; Vorwerk P; Fritsche K; Richter R
Kinderarztl Prax; 1993 May; 61(3):108-11. PubMed ID: 8326698
[TBL] [Abstract][Full Text] [Related]
8. Mammalian cardenolides in cancer prevention and therapeutics.
Al-Ghoul M; Valdes R
Ther Drug Monit; 2008 Apr; 30(2):234-8. PubMed ID: 18367987
[TBL] [Abstract][Full Text] [Related]
9. A new interference in some digoxin assays: anti-murine heterophilic antibodies.
Liendo C; Ghali JK; Graves SW
Clin Pharmacol Ther; 1996 Nov; 60(5):593-8. PubMed ID: 8941034
[TBL] [Abstract][Full Text] [Related]
10. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
Dasgupta A
Am J Clin Pathol; 2002 Jul; 118(1):132-40. PubMed ID: 12109847
[TBL] [Abstract][Full Text] [Related]
11. [High digoxin serum levels in an elderly patient for the endogenous digoxin-like immunoreactive substances. A case report].
Suppa M; Giancaspro G; Coppola A; Colzi M; Marini ME; Magnanelli E; Baldini E; Cavicchi F; Petroni C; Contu E; Boccardo C; Scarpellini MG
Clin Ter; 2011; 162(3):245-8. PubMed ID: 21717052
[TBL] [Abstract][Full Text] [Related]
12. Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy.
Graves SW; Lincoln K; Cook SL; Seely EW
Am J Hypertens; 1995 Jan; 8(1):5-11. PubMed ID: 7734097
[TBL] [Abstract][Full Text] [Related]
13. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors.
Graves SW; Sharma K; Chandler AB
Clin Chem; 1986 Aug; 32(8):1506-9. PubMed ID: 3755385
[TBL] [Abstract][Full Text] [Related]
14. Endogenous digoxin-immunoactive factor in human subjects.
Valdes R
Fed Proc; 1985 Sep; 44(12):2800-5. PubMed ID: 3839758
[TBL] [Abstract][Full Text] [Related]
15. Endogenous digoxin-like immunoreactive factors eliminated from serum samples by hydrophobic silica-gel extraction and enzyme immunoassay.
Skogen WF; Rea MR; Valdes R
Clin Chem; 1987 Mar; 33(3):401-4. PubMed ID: 3545537
[TBL] [Abstract][Full Text] [Related]
16. Evidence for presence of a reduced form of digoxin-like immunoreactive factor (dihydro-DLIF) in mammalian tissues.
Qazzaz HM; Jortani SA; Poole JM; Valdes R
Clin Chem; 1996 Jul; 42(7):1092-9. PubMed ID: 8674194
[TBL] [Abstract][Full Text] [Related]
17. Evidence of marked digoxin-like immunoreactivity in the human adrenal cortex: results of an immunohistochemical study.
Ghione S; Balzan S; Braus S; Montali U; Bruno J
Eur J Histochem; 1993; 37(3):273-6. PubMed ID: 7693066
[TBL] [Abstract][Full Text] [Related]
18. Detection of endogenous digitalis-like immunoreactive factors in human blood.
Lin MH; Liao CP; Lee JS; Chin YW; Hsu CC; Wei JS
Proc Natl Sci Counc Repub China B; 1998 Jul; 22(3):129-35. PubMed ID: 9779602
[TBL] [Abstract][Full Text] [Related]
19. Improved interassay correlation of digoxin results in patients with and without renal failure by elimination of digoxin-like immunoreactive factors.
Skogen WF; Rea MR; Valdes R
Clin Chem; 1987 Jun; 33(6):837-9. PubMed ID: 3594830
[TBL] [Abstract][Full Text] [Related]
20. Dialyzability and binding of digoxin-like immunoreactive factors (DLIF) with serum macromolecules in uremic patients on hemodialysis.
Dasgupta A; Peng Y
Life Sci; 1991; 49(22):1603-9. PubMed ID: 1943464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
